Concepedia

Natesan Murugesan

NM

30

Publications

1.4K

Citations

22

H-Index

1979

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Pennsylvania State University

University of Virginia

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Natesan Murugesan is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1979–2020

30

Publications

30

The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide

Philip D. Stein, John T. Hunt, David Floyd et al. · Journal of Medicinal Chemistry · 1994 · 137 citations · Full text

, , +16

Bleomycin as an oxene transferase. Catalytic oxygen transfer to olefins

Natesan Murugesan, Sidney M. Hecht · Journal of the American Chemical Society · 1985 · 89 citations

, , +16

Dual Angiotensin II and Endothelin A Receptor Antagonists:  Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics

Natesan Murugesan, Zhengxiang Gu, Leena Fadnis et al. · Journal of Medicinal Chemistry · 2004 · 86 citations

, , +16

Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG)

Hiroshi Sugiyama, Cheng Xu, Natesan Murugesan et al. · Biochemistry · 1988 · 83 citations

Analysis of products formed during bleomycin-mediated DNA degradation

Natesan Murugesan, Cheng Xu, Guy M. Ehrenfeld et al. · Biochemistry · 1985 · 72 citations

Rows per page

1–5 of 30